Strategic Partnerships Teva Canada actively collaborates with global partners (e.g., relaunchs Mayzent with Novartis Canada) which signals openness to co-promotion, licensing, and joint market access opportunities that sales teams can leverage for new product launches or portfolio expansions.

Cannabis and CNS Focus Strength in CNS, respiratory and oncology through Teva’s global specialty portfolio presents cross-sell potential for Canada by aligning generic and specialty medicines, devices and support services to address unmet patient needs in neurology, pain, and respiratory care.

Regulatory and Safety Emphasis Recent voluntary recalls and regulatory notifications underscore the importance of robust quality assurance and patient safety wins; there is opportunity to position services around supply chain integrity, compliance management, and proactive risk mitigation for hospital and retail channels.

Public Market Presence With a long-standing Canadian footprint since 1965 and substantial local employment, Teva Canada is a trusted national supplier; this opens avenues for government and payer engagement, formulary access strategies, and private-sector partnership programs.

Leadership and Growth Recent leadership changes and ongoing launches (e.g., Life Effects platform, Aermony RespiClick) indicate a growth-focused strategy with expansion into patient support, digital health, and preventive therapies that sales teams can target for patient programs, clinical partnerships, and insurer collaboration.